Browse 4 Alli Medical Studies Across 4 Cities
4 Alli Clinics
What Are Alli Clinical Trials?
Alli is a brand name variant of a drug named Orlistat that blocks the absorption of fat from food, thereby acting as an aid to weight loss. It is considered effective when use is combined with a low-fat diet and a healthy fitness routine.
Due to its tendency to reduce the ability of the body to metabolize fat from food, Alli is being studied for its ability to reduce triglyceride levels, as a treatment for obesity, type 2 diabetes mellitus, and obstructive sleep apnea. Because these conditions have a great deal of causal and symptomatic overlap, it is believed that the effects researchers are looking for have a high probability of manifesting in clinical trials.
Why Is Alli Being Studied In Clinical Trials?
Alli is one of the most popular prescription weight loss drugs ever made, and its success has made it possible for doctors, clinicians, and researchers to gather an enormous amount of data on its use, effects, and safety. Overall, the currently ongoing studies have demonstrated very high levels of safety, and moderate levels of effectiveness.
While the effectiveness of Alli in use as a treatment for type 2 diabetes Mellitus, has been high, success in reducing high triglyceride levels and obstructive sleep apnea has been moderate at best. However, because of the strong physiological connection between these conditions and obesity, and because Alli is known to be an effective treatment for obesity, the researchers behind these studies remain hopeful.
How Does Alli Treatment Work?
Alli is taken with liquid either while eating or after a meal. It is best to take it with food or within one hour after eating. An hour after eating is considered the latest point at which it should still be effective in blocking the absorption of fats.
Alli works by blocking the action of lipases. These are enzymes that attach to and carry fat through the tissues of the digestive tract into the bloodstream, thereby removing the mechanism by which fat is absorbed.
Alli is meant to be taken three times a day at most, or once with each meal. The greatest concern with this drug is that users may consume more fat than they would normally consume, and thereby overwhelm the ability of the Alli to work. Aside from this, safety concerns are considered moderate to low.
What Are Some of the Breakthrough Clinical Trials Involving Alli?
The following studies are only a sample of the dozens of promising clinical trials that have been and are being conducted concerning the weight loss drug, Alli.
First clinical studies with Alli: a short review
Alli Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia
Multifactorial Approach Associated With Alli for 4 Years Weight Loss Maintenance in Obese Adults
Who Are The Key Opinion Leaders On Alli Clinical Trial Research?